Last $148.72 USD
Change Today +5.29 / 3.69%
Volume 2.2M
SLXP On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitleKey Developments
Thomas D'Alonzo Esq., J.D. 43 RelationshipsChairman, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee 
John Chappell 8 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee 
Mark Sirgo Pharm.D. 21 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit Committee 
William Keane M.B.A. 5 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee 

Compensation Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitle
John Chappell 8 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Thomas D'Alonzo Esq., J.D. 43 RelationshipsChairman, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
William Keane M.B.A. 5 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Mark Sirgo Pharm.D. 21 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit Committee
SLXP Compensation vs. Industry
867.5K
434.0K
Chief Executive Officer
488.9K
270.7K
Chief Financial Officer
Share price activity for SALIX PHARMACEUTICALS LTD (SLXP)
52 Week Price Performance
SLXP
Industry Average

Nominating Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitleKey Developments
Thomas D'Alonzo Esq., J.D. 43 RelationshipsChairman, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation CommitteeSalix Pharmaceuticals Ltd. Appoints Mark A. Sirgo to its Board of Directors
02/6/08
John Chappell 8 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation CommitteeSalix Pharmaceuticals Ltd. Appoints William Harral as Additional Independent Director
10/4/05
Mark Sirgo Pharm.D. 21 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit CommitteeSalix Pharmaceuticals Appoints William P. Forbes as Vice President, Research and Development and Chief Development Officer
02/8/05
William Keane M.B.A. 5 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation CommitteeSalix Pharmaceuticals Ltd. Appoints William Forbes as Vice President, Research and Development and Chief Development Officer
01/25/05

Corporate Governance Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitle
John Chappell 8 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Thomas D'Alonzo Esq., J.D. 43 RelationshipsChairman, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
William Keane M.B.A. 5 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Mark Sirgo Pharm.D. 21 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit Committee
SLXP and Competitor
Insiders vs. External
Board
20%
80%
Salix Pharmaceuticals Ltd.
25%
75%
Alkermes plc
13%
87%
Cubist Pharmaceuticals Inc.
20%
80%
Recordati SpA
9%
91%
Jazz Pharmaceuticals Public Limited Company
40%
60%
Lupin Limited
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLXP:US $148.72 USD +5.29

SLXP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $43.68 USD -0.67
Cubist Pharmaceuticals Inc $66.16 USD -0.98
Jazz Pharmaceuticals PLC $160.35 USD -9.05
Lupin Ltd 1,397 INR -19.40
Recordati SpA €12.50 EUR +0.07
View Industry Companies
 

Industry Analysis

SLXP

Industry Average

Valuation SLXP Industry Range
Price/Earnings 100.0x
Price/Sales 7.2x
Price/Book 12.4x
Price/Cash Flow 47.8x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SALIX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.